Skip to main content
OpenTrials

Clinical trial condition

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Explore clinical trials studying Human Immunodeficiency Virus Type 1 (HIV-1) Infection. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Human Immunodeficiency Virus Type 1 (HIV-1) Infection trial results

Recruiting

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

NCT07266831

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group, Inc. ( Site 1513) Los Angeles, California, United States
  • Vivent Health ( Site 1519) Denver, Colorado, United States
  • Whitman-Walker Institute ( Site 1538) Washington D.C., District of Columbia, United States
  • Midway Immunology and Research Center ( Site 1503) Ft. Pierce, Florida, United States
View all 55 locations
View Trial Details
Active, Not Recruiting

A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)

NCT06891066

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Zuckerberg San Francisco General Hospital and Trauma Center ( Site 4107) San Francisco, California, United States
  • Mills Clinical Research ( Site 4109) West Hollywood, California, United States
  • Georgetown University Medical Center ( Site 4106) Washington D.C., District of Columbia, United States
  • Orlando Immunology Center ( Site 4103) Orlando, Florida, United States
View all 23 locations
View Trial Details

Related conditions